Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency

胰岛素 内分泌学 激素 医学 分泌物 内科学 神经递质 小岛 中枢神经系统
作者
Wei Xia,Ting Wang,Jia‐Yan Pan
出处
期刊:World Journal of Clinical Cases [Baishideng Publishing Group]
卷期号:11 (28): 6715-6724 被引量:1
标识
DOI:10.12998/wjcc.v11.i28.6715
摘要

With the improvement of economy and living standards, the attention paid to short stature in children has been increasingly highlighted. Numerous causes can lead to short stature in children, among which growth hormone deficiency (GHD) is a significant factor.To investigate the long-term efficacy and safety of different doses of long-acting polyethylene glycol recombinant human growth hormone (PEG-rhGH) in the treatment of GHD in children.We selected 44 pediatric patients diagnosed with GHD who were treated at Wuhu First People's Hospital from 2014 to 2018. Total 23 patients were administered a high dose of long-acting PEG-rhGH at 0.2 mg/kg subcutaneously each week, forming the high-dose group. Meanwhile, 21 patients were given a lower dose of long-acting PEG-rhGH at 0.14 mg/kg subcutaneously each week, establishing the low-dose Group. The total treatment period was 2 years, during which we monitored the patients' height, annual growth velocity (GV), height standard deviation score (HtSDS), chronological age (CA), bone age (BA), and serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) before treatment and at 6 mo, 1 year, and 2 years after treatment initiation. We also monitored thyroid function, fasting plasma glucose, fasting insulin, and other side effects. Furthermore, we calculated the homeostatic model assessment for insulin resistance.After 1 year of treatment, the GV, HtSDS, IGF-1, BA, and IGFBP-3 in both groups significantly improved compared to the pre-treatment levels (P < 0.05). Moreover, when comparing GV, HtSDS, IGF-1, BA, and IGFBP-3 between the two groups, there were no statistically significant differences either before or after the treatment (P > 0.05). During the treatment intervals of 0-1.0 years and 1.0-2.0 years, both patient groups experienced a slowdown in GV and a decline in HtSDS improvement (P < 0.05).The use of PEG-rhGH in treating GHD patients was confirmed to be effective, with similar outcomes observed in both the high-dose group and low-dose groups, and no significant differences in the main side effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
墨然然完成签到 ,获得积分10
刚刚
Dr.Li发布了新的文献求助50
刚刚
清浅完成签到,获得积分10
1秒前
王冉冉发布了新的文献求助10
2秒前
3秒前
所所应助zjz采纳,获得30
4秒前
4秒前
小吴同学发布了新的文献求助10
5秒前
量子星尘发布了新的文献求助10
5秒前
5秒前
6秒前
shaocat完成签到 ,获得积分10
6秒前
风中的眼神完成签到,获得积分10
6秒前
CAOHOU应助奋斗水香采纳,获得10
7秒前
俊逸梦蕊完成签到,获得积分10
7秒前
8秒前
典雅牛青关注了科研通微信公众号
8秒前
Xinxxx发布了新的文献求助10
8秒前
illusion完成签到,获得积分10
9秒前
wanci应助王冉冉采纳,获得30
10秒前
树小夏发布了新的文献求助10
11秒前
小吴同学完成签到,获得积分10
11秒前
赘婿应助kk_yang采纳,获得10
12秒前
成就伟祺关注了科研通微信公众号
13秒前
能干的语芙完成签到 ,获得积分10
13秒前
无欲无求傻傻完成签到,获得积分10
13秒前
13秒前
13秒前
尊敬寒松完成签到 ,获得积分10
13秒前
糊涂的麦片完成签到,获得积分10
13秒前
14秒前
14秒前
15秒前
wanci应助wangdafa采纳,获得10
15秒前
竹子co完成签到,获得积分10
15秒前
steventj完成签到,获得积分10
15秒前
yz完成签到 ,获得积分10
16秒前
朴实山兰完成签到,获得积分10
17秒前
tkkdy发布了新的文献求助10
17秒前
蓁蓁发布了新的文献求助10
17秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066